{"status": "OK", "response": {"docs": [{"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-9 Defiant North Korea Orders Inspectors Out North Korea announced it would expel all international nuclear inspectors and restart a nuclear fuel reprocessing laboratory. The United Nations agency that monitors nuclear activity said that its three inspectors were staying, and demanded that North Korea restore cameras and seals. Top Bush administration officials reiterated that North Korea must reverse course. A1 Scientist Rebuffs Inspectors United Nations weapons inspectors interviewed an Iraqi scientist, but Iraq immediately downplayed the significance of the interview. The scientist called in to a television show to dismiss the idea that he knew anything about the nuclear program. A10", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1305, "_id": "4fd28dbf8eb7c8105d863727", "snippet": "INTERNATIONAL   A3-9    Defiant North Korea Orders Inspectors Out  North Korea announced it would expel all international nuclear inspectors and restart a nuclear fuel reprocessing laboratory. The United Nations agency that monitors nuclear activity...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/28/nyregion/news-summary-597945.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2002-12-28T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-19 Declining Fertility Rates Reshape Europe's Future Italy, Spain, Sweden, Germany and Greece are now feeling the consequences of decades of low fertility rates: less-competitive work forces, surfeits of retirees and pension systems that will need to be cut back deeply. A1 New U.S. Radar for Qatar The United States military has set up a sophisticated ground-radar system in Qatar to help protect allied and American forces in the Persian Gulf region from Iraqi missile attacks, military officials say. These new radars are only used overseas in Germany and South Korea. A22", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1378, "_id": "4fd23f628eb7c8105d7d6746", "snippet": "INTERNATIONAL   A3-19    Declining Fertility Rates Reshape Europe's Future  Italy, Spain, Sweden, Germany and Greece are now feeling the consequences of decades of low fertility rates: less-competitive work forces, surfeits of retirees and pension...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/26/nyregion/news-summary-566780.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2002-12-26T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Drug companies and doctors are fighting a Bush administration plan to restrict gifts and other rewards that pharmaceutical manufacturers give doctors and insurers to encourage the prescribing of particular drugs. In October, the Department of Health and Human Services said many gifts and gratuities were suspect because they looked like illegal kickbacks. Since then, a few consumer groups, including AARP, have voiced support for the restrictions. But they are outnumbered by the drug makers, doctors and health maintenance organizations that have flooded the government with letters criticizing the proposal.", "headline": {"main": "Drug Makers Battle A U.S. Plan to Curb Rewards for Doctors"}, "abstract": "Drug companies and doctors fight Bush administration plan to restrict gifts and other rewards that pharmaceutical manufacturers give doctors and insurers to encourage prescribing of particular drugs; Dept of Health and Human Services says many gifts and gratuities look like illegal kickbacks, and consumer groups including AARP voice support for restrictions; they are outnumbered by drug makers, doctors and health maintenance organizations that have flooded government with letters criticizing proposal; drug makers acknowledge that they routinely make payments to insurance plans to increase use of their products, to expand their market share, to be added to lists of recommended drugs or to reward doctors and pharmacists for switching patients from one brand of drug to another; insurers, doctors and drug makers say such payments are so embedded in structure of health care industry that Bush administration plan would be profoundly disruptive; doctors say drug companies are major source of money for their professional education programs; administration says it is considering these comments and expects to issue final guidelines in few months (M)", "print_page": "1", "word_count": 1265, "_id": "4fd26c688eb7c8105d824b3c", "snippet": "Drug companies and doctors are fighting a Bush administration plan to restrict gifts and other rewards that pharmaceutical manufacturers give doctors and insurers to encourage the prescribing of particular drugs.    In October, the Department of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/26/us/drug-makers-battle-a-us-plan-to-curb-rewards-for-doctors.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "organizations", "value": "HEALTH AND HUMAN SERVICES DEPARTMENT"}, {"name": "organizations", "value": "AARP"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "GIFTS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "BRIBERY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-12-26T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "State efforts to provide prescription drugs to low-income people suffered a setback today as the United States Court of Appeals here struck down a pioneering program established by the State of Maine. The program, approved by the federal government nearly two years ago, forced drug makers to give discounts of 18 percent to 25 percent.", "headline": {"main": "Law Requiring Lower Drug Prices Is Struck Down"}, "abstract": "Federal appeals court strikes down Maine's program that requires drug makers to sell drugs to state Medicaid programs at discounts that typically reduce retail prices by 18 percent and to give similar discounts to tens of thousands of people who earn too much to qualify for Medicaid; finds that goal of program is to provide prescription drug benefit without creating net costs for state, placing entire burden in drug companies; program was approved by Department of Health and Human Services in waning days of Clinton administration and was challenged by drug industry; number of states have filed bills to establish drug-discount programs like one in Maine (M)", "print_page": "1", "word_count": 1000, "_id": "4fd220808eb7c8105d7a421f", "snippet": "State efforts to provide prescription drugs to low-income people suffered a setback today as the United States Court of Appeals here struck down a pioneering program established by the State of Maine.    The program, approved by the federal...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/25/us/law-requiring-lower-drug-prices-is-struck-down.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "MAINE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "DECISIONS AND VERDICTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2002-12-25T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Dr. Ron Livesey was fat, tired and out of shape. At 49, he felt that his best years were behind him. So one day seven years ago, on his way to a medical meeting, he stopped at a doctor's office in Palm Springs, Calif., for his first hormone injections.", "headline": {"main": "Chasing Youth, Many Gamble On Hormones"}, "abstract": "Doctors in US are offering anti-aging treatments even though effectiveness has not been established and long-term risks are ill defined; treatment is expensive: $1,000 a month for panoply of drugs and dietary supplements, including human growth hormone and testosterone for men and women, estrogen and progesterone for women, melatonin, DHEA, vitamins and antioxidants; photos (M)", "print_page": "1", "word_count": 1505, "_id": "4fd2233c8eb7c8105d7a8ecc", "snippet": "Dr. Ron Livesey was fat, tired and out of shape. At 49, he felt that his best years were behind him.    So one day seven years ago, on his way to a medical meeting, he stopped at a doctor's office in Palm Springs, Calif., for his first hormone...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/22/us/chasing-youth-many-gamble-on-hormones.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "TESTOSTERONE"}, {"name": "subject", "value": "DIETARY SUPPLEMENTS AND HERBAL REMEDIES"}, {"name": "subject", "value": "VITAMINS"}, {"name": "subject", "value": "PROGESTERONE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "HUMAN GROWTH HORMONE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MELATONIN (HORMONE)"}, {"name": "subject", "value": "DHEA (DIHYDROEPIANDROSTERONE) (HORMONE)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2002-12-22T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 5, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}